As part of a stakeholder consultation on the childhood pneumococcal vaccination schedule, responses were sought from Pfizer, GlaxoSmithKline, Merck, Meningitis Now, and the Meningitis Research Foundation. Additional responses were received from the Confederation of Meningitis Organisations, the International Federation of Ageing, and the International Longevity Centre.
The Joint Committee on Vaccination and Immunisation (JCVI) Pneumococcal sub-committee considered the responses received on 10 May 2018. The sub-committee reported to the JCVI on 6 June 2018. The minutes of these meetings will provide the Committee’s response to points raised during the consultation and will be published on or before 18 July 2018.